About
Provided by Felsberg Advogados
Felsberg Advogados’ Life Sciences practice is recognised for its multidisciplinary expertise in regulatory, transactional and contentious matters. The team advises on regulatory issues, intellectual property, licensing, technology transfer, product liability, M&A and strategic matters affecting highly regulated companies.
The practice assists clients across all business stages, from early-stage biotech and medical device companies to multinational pharmaceutical manufacturers, healthcare providers and health and wellness companies. Its work combines industry knowledge with practical advice to support market entry, expansion, partnerships and risk management.
The team has a strong track record advising on Brazilian regulatory frameworks involving the Ministry of Health, ANVISA, ANS and MAPA. It represents clients in sanctioning proceedings before ANVISA, ANS and municipal health surveillance authorities, and advises on product registration, price adjustments, advertising campaigns, product labels, public procurement and contracts with the Ministry of Health.
The practice also supports clients in compliance and corporate ethics policies aligned with regulatory requirements and international best practices, as well as in distribution and outsourcing contracts involving controlled substances. With deep experience across the pharmaceutical, healthcare, food, cosmetics and hygiene sectors, the team advises domestic and international clients seeking to enter or expand in Brazil.